These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6182816)

  • 1. Anti-IgG antibodies during immunotherapy with purified grass pollen extracts.
    Osterballe O; Egeskjold EM; Johansen AS; Skov P
    Allergy; 1982 Apr; 37(3):209-16. PubMed ID: 6182816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgG antibodies and antinuclear antibodies in allergic patients.
    Egeskjold EM; Permin H; Nielsen I; Sørensen HJ; Osterballe O; Kallerup HE
    Allergy; 1981 Nov; 36(8):573-81. PubMed ID: 6978090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever.
    Kay AB
    Drugs Today (Barc); 2007 Dec; 43(12):841-8. PubMed ID: 18174969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with grass pollen major allergens.
    Osterballe O
    Allergy; 1982 Aug; 37(6):379-88. PubMed ID: 7137533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
    Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
    Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyposensitization for tree pollinosis on associated apple allergy.
    Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L
    J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of hyposensitization using a purified allergen preparation from Timothy pollen as compared to crude aqueous extracts from Timothy pollen and a four-grass pollen mixture respectively.
    Frostad AB; Grimmer O; Sandvik L; Moxnes A; Aas K
    Clin Allergy; 1983 Jul; 13(4):337-57. PubMed ID: 6136346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy.
    Machiels JJ; Somville MA; Jacquemin MG; Saint-Remy JM
    Allergy; 1991 Jul; 46(5):335-48. PubMed ID: 1928657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific IgE and IgG antibody responses in children to timothy pollen components during immunotherapy.
    Nordvall SL; Renck B; Einarsson R
    Allergy; 1989 Aug; 44(6):380-4. PubMed ID: 2802111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
    Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
    Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects during immunotherapy with purified grass pollen extracts.
    Osterballe O
    Allergy; 1982 Nov; 37(8):553-62. PubMed ID: 7181051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyposensitization. Comparing a purified (refined) allergen preparation and a crude aqueous extract from timothy pollen.
    Frostad AB; Grimmer O; Sandvik L; Aas K
    Allergy; 1980 Mar; 35(2):81-95. PubMed ID: 7386802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.